T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: A study using HLA DQ8 and DQ6 transgenic mice

Human Immunology

Volumn 58, Issue 1, 1997, Pages 21-29

  Raju, Raghavanpillai ^a   Munn, Stephen R ^b   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ALLELE; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; GENE LOCUS; GENETIC POLYMORPHISM; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HLA-DQ ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYMORPHISM, GENETIC; PROINSULIN; PROTEIN PRECURSORS; T-LYMPHOCYTES;

EID: 0031456751     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00212-7     Document Type: Article

References (36)

1. Eisenbarth GS. Diabetes Mellitus A chronic autoimmune disease . N Engl J Med. 314:1986;360.
2. Lernmark A: Molecular biology of IDDM. Diabetologia 37:Supp2:S73, 1994.
3. Atkinson MA, Maclaren NK. Islet cell autoantgens in insulin dependent diabetes. J Clin Invest. 92:1993;1608.
4. Bohmer K, Keilacker H, Kuglin B, et al. Proinsulin autoantibodies are more closely associated with type I (insulin dependent) diabetes mellitus than insulin autoantibodies. Diabetologia. 34:1991;830.
5. Keller KJ. Cellular immunity to human insulin in individuals at risk for the development of type I diabetes mellitus. J Autoimmunity. 3:1990;312.
6. Harrison LC, De Aizpurua H, Loudivaris T, Campbell IL, Cebon JS, Tait BD, Colman PG. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes. 40:1991;1128.
7. Miller GG, Pollack MS, Nell LJ. Insulin-specific human T cells Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes associated haplotype . J Immunol. 139:1987;3622.
8. Wegmann D, Norbury-Glaser M, Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol. 24:1994;1853.
9. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin specific T cell clones isolated from NOD mice. Eur J Immunol. 25:1995;1056.
10. Daniel D, Wegmann D. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B (9-23). Proc Natl Acad Sci USA. 93:1996;956.
11. Nepom GT, Erlick H. MHC class II molecules and autoimmunity. Ann Rev Immunol. 9:1991;493.
12. Kockum I, Wassmuth R, Holmberg E, et al. HLA-DQ protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population based affected families and controls. Am J Human Genet. 42:1993;150.
13. Yamamoto K, Fukui Y, Esaki Y, Inamitsu T, Sudo T, Yamane K, Kamikawaji N, Kimura A, Sasazuki T. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J Exp Med. 180:1994;165.
14. Altmann DM, Douek CD, Frater AJ, Hetherington CM, Inoko H, Elliot JI. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. Exp Med. 181:1995;867.
15. Wei B-Y, Martin J, Savarirayan S, Little R, David CS: Transgenic mice with MHC class II genes: The use in the study of allelic a/b chain pairing and the production of engineered mice with mutant I-A genes in Egorov IK, David CS, Transgenic mice and mutants in MHC research (eds).: (Berlin Heidelberg), Springer-Verlag, p. 237, 1990.
16. Nishimura Y, Iwanaga T, Inamitsu T, Yanagawa Y, Yasunami M, Kimura A, Hirokawa K, Sasazuki T. Expression of the human HLA-DQw6 genes alters the immune response in C57BL/6 mice. J Immunol. 145:1990;353.
17. Okada K, Boss JM, Prentice H, Spies T, Mengler R, Auffray C, Lillie J, Grossberger D, Strominger JL. Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc Natl Acad Sci USA. 82:1985;3410.
18. Cosgrove C, Gray C, Deirich A, Kaufman J, Lemeur M, Benoist C, Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051.
19. Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen induced arthritis A novel model for human polyarthritis . J Exp Med. 183:1996;27.
20. Neeno T, Krco CJ, Harders J, Baisch J, Cheng S, David CS. HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens. J Immunol. 156:1996;3191.
21. Krco CJ, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra HS, David CS. Identification of HLA-DQ restricted T cell epitopes on dust mite grass, and weed allergens using HLA-DQ6 transgenic mice. J Immunol. 156:1996;2761.
22. Muir A, Peck A, Clare-Salzler M, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intra-islet interferon g transcription. J Clin Invest. 95:1995;628.
23. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA. 88:1991;10252.
24. Griffin AC, Zhao W, Wegmann KW, Hickey WF. Experimental autoimmune insulitis Induction by T lymphocytes specific for a peptide of proinsulin . Am J Pathol. 147:1995;845.
25. Hampl J, Gradehandt G, Kalbacher H, Rude E. In vitro processing of insulin for recognition by murine T cells results in the generation of A chains with free CysSH. J Immunol. 148:1992;2664.
26. Rosenwasser LJ, Barcinski MA, Schwartz RH, Rosenthal AS. Immune response gene control of determinant selection. J Immunol. 123:1979;471.
27. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeyman MC, Tait B, Lew AM. Similar peptides from two b cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med. 1:1995;625.
28. England RD, Kullberg MC, Cornette JL, Berzofsky JA. Molecular analysis of a heteroclitic T cell response to the immunodominant epitope of sperm whale myoglobin Implications for peptide partial agonists . J Immunol. 155:1995;4295.
29. Kwok WW, Domeier ME, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterized HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol. 156:1996;2171.
30. Nepom GT. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes. 39:1990;1153.
31. Sheehy MJ. HLA and insulin-dependent diabetes A protective perspective . Diabetes. 41:1992;123.
32. She J-X. Susceptibility to type I diabetes HLA DQ and DR revisited . Immunol Today. 17:1996;323.
33. Mally MI, Cirulli V, Otonkoski T, Soto G, Hayek A. Ontogeny and tissue distribution of human GAD expression. Diabetes. 45:1996;496.
34. Solimena M, Butler MH, De Camilli P. GAD, diabetes, and Stiff-Man syndrome some progress and more questions . J Endocrinol Invest. 17:1994;509.
35. Eisenbarth GS. Mouse or man Is GAD the cause of type I diabetes? Diabetes Care. 17:1994;605.
36. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity Viral peptides activate human T cell clones specific for myelin basic protein . Cell. 80:1995;695.